A‐L Børresen‐Dale

Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome

Anna Bergamaschi, Elda Tagliabue, Thérese Sørlie et al. · The Journal of Pathology · 2007 · 385 citations

Medicine, Molecular Biology, Oncology +17

TP53 mutations in early-stage ovarian carcinoma, relation to long-term survival

Yun Wang, Åslaug Helland, Ruth Holm et al. · British Journal of Cancer · 2004 · 68 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors

Jørgen Aarøe, FE Johansen, James Hicks et al. · BMC Genomics · 2008 · 65 citations · Full text

Life Sciences, Genetics, Oncology +17

Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene status

Birgitte Smith‐Sørensen, Ruth Holm, Anne Dørum et al. · British Journal of Cancer · 1998 · 56 citations · Full text

Medicine, Oncology, Pharmacology +14

Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load

Åslaug Helland, Frank Karlsen, EU Due et al. · British Journal of Cancer · 1998 · 29 citations

Medicine, Molecular Genetics, Oncology +15